CoChat

Emerging Indications for Statins: A Pluripotent Family of Agents with Several Potential Applications

The DOI matches its Crossref record.

Abstract

Statins are pluripotent agents exhibiting multiple non-lipid-lowering actions. Besides their established role in the management of hypercholesterolemia, statins may also have beneficial actions in other pathological conditions, namely: a) osteoporosis and osteoporosis-related bone fractures, b) cancer, c) solid organ transplantation, d) cerebrovascular events (transient ischemic attack and stroke episodes), e) various neurological disorders, such as Alzheimer's disease, Parkinson's disease and multiple sclerosis, f) cardiac arrhythmias and heart failure, g) renal diseases, h) rheumatoid arthritis, i) autoimmune diseases, j) sepsis, and k) allergic asthma. We reviewed the literature searching for studies that support or oppose the use of statins in each proposed indication. In some of these emerging indications, a role for statin treatment is more firmly set; for others, current evidence is more controversial. Future trials may reveal more convincing evidence that will make statin use necessary in the therapeutic management of several diseases.

Overview

Integrity signals

Registry

Crossref · 10.2174/138161207782794194

Cites

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Still being checked.

Cited by

See all 70

Metadata

Authors
Paraskevas, K., Tzovaras, A., Briana, D., & Mikhailidis, D.
Affiliations
The Royal Free Hospital (GB)
Venue
Current Pharmaceutical Design
Published
2007-12-01
Volume
13
Issue
35
Pages
3622-3636
ISSN
1381-6128 (ISSN-L)
OpenAlex
W2164463284
Cited by
70
References
0
Citations by year
2024: 2 · 2022: 1 · 2020: 1 · 2019: 2 · 2018: 2 · 2017: 1 · 2016: 1 · 2015: 2 · 2014: 3 · 2013: 4 · 2012: 10
FWCI
11.62
Type
journal article
Language
en
Open access
closed
Locations
  • Current Pharmaceutical Design (publishedVersion)
  • PubMed (publishedVersion)
  • UCL Discovery (University College London) (submittedVersion)
Topics
  • Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Lipoproteins and Cardiovascular Health
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer, Lipids, and Metabolism
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Cholesterol and Lipid Metabolism
Keywords
statins, off-label drug use, osteoporosis, bone fractures, cancer, solid organ transplantation, cerebrovascular disease, stroke, transient ischemic attack, Alzheimer's disease, Parkinson's disease, multiple sclerosis, cardiac arrhythmias, heart failure, kidney disease, rheumatoid arthritis, autoimmune disease, sepsis, allergic asthma
MeSH terms
Animals, Antineoplastic Agents, Arthritis, Rheumatoid, Asthma, Autoimmune Diseases, Cardiovascular Agents, Cerebrovascular Disorders, Heart Diseases, Humans, Kidney Diseases, Neoplasms, Nervous System Diseases, Osteoporosis, Organ Transplantation, Antirheumatic Agents, Neuroprotective Agents, Sepsis, Anti-Asthmatic Agents, Hydroxymethylglutaryl-CoA Reductase Inhibitors, Bone Density Conservation Agents

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Emerging Indications for Statins: A Pluripotent Family of Agents with Several Potential Applications. https://app.cochat.ai/papers/10.2174/138161207782794194
The paper
Paraskevas, K., Tzovaras, A., Briana, D., & Mikhailidis, D. (2007). Emerging Indications for Statins: A Pluripotent Family of Agents with Several Potential Applications. Current Pharmaceutical Design. https://doi.org/10.2174/138161207782794194

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.